 |
PDBsum entry 2p3f
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of the factor xa/nap5 complex
|
|
Structure:
|
 |
Coagulation factor x. Chain: h. Fragment: activated factor xa heavy chain domain. Synonym: stuart factor, stuart-prower factor. Coagulation factor x. Chain: l. Fragment: egf-like 2 domain. Synonym: stuart factor, stuart-prower factor. Anti-coagulant protein 5.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Ancylostoma caninum. Dog hookworm. Organism_taxid: 29170
|
|
Resolution:
|
 |
|
3.10Å
|
R-factor:
|
0.180
|
R-free:
|
0.280
|
|
|
Authors:
|
 |
J.L.Rios-Steiner,M.T.Murakami,A.Tulinsky,R.K.Arni
|
Key ref:
|
 |
J.L.Rios-Steiner
et al.
(2007).
Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.
J Mol Biol,
371,
774-786.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Mar-07
|
Release date:
|
06-Nov-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00742
(FA10_HUMAN) -
Coagulation factor X from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
488 a.a.
235 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains H, L:
E.C.3.4.21.6
- coagulation factor Xa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
371:774-786
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.
|
|
J.L.Rios-Steiner,
M.T.Murakami,
A.Tulinsky,
R.K.Arni.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hookworms are hematophagous nematodes capable of growth, development and
subsistence in living host systems such as humans and other mammals.
Approximately one billion, or one in six, people worldwide are infected by
hookworms causing gastrointestinal blood loss and iron deficiency anemia. The
hematophagous hookworm Ancylostoma caninum produces a family of small,
disulfide-linked protein anticoagulants (75-84 amino acid residues). One of
these nematode anticoagulant proteins, NAP5, inhibits the amidolytic activity of
factor Xa (fXa) with K(i)=43 pM, and is the most potent natural fXa inhibitor
identified thus far. The crystal structure of NAP5 bound at the active site of
gamma-carboxyglutamic acid domainless factor Xa (des-fXa) has been determined at
3.1 A resolution, which indicates that Asp189 (fXa, S1 subsite) binds to Arg40
(NAP5, P1 site) in a mode similar to that of the BPTI/trypsin interaction.
However, the hydroxyl group of Ser39 of NAP5 additionally forms a hydrogen bond
(2.5 A) with His57 NE2 of the catalytic triad, replacing the hydrogen bond of
Ser195 OG to the latter in the native structure, resulting in an interaction
that has not been observed before. Furthermore, the C-terminal extension of NAP5
surprisingly interacts with the fXa exosite of a symmetry-equivalent molecule
forming a short intermolecular beta-strand as observed in the structure of the
NAPc2/fXa complex. This indicates that NAP5 can bind to fXa at the active site,
or the exosite, and to fX at the exosite. However, unlike NAPc2, NAP5 does not
inhibit fVIIa of the fVIIa/TF complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Alignment of amino acid sequences of NAP5, NAP6 and
NAPc2. Differences from NAP5 are in bold; disulfide bonds are
shown as black lines; the conserved motif involved in exosite
binding id boxed in dark gray; non-conserved motifs involved in
the exosite binding boxed are in light gray; the NAP5 sequence
is numbered consecutively.
|
 |
Figure 2.
Figure 2. Stereoview of the superpositioning of C/E-1 on
NAP5. A ribbon representation of NAP5 is in blue, the NAP5
disulfide bridges are numbered, reactive-site P1 residues are
shown as yellow sticks (Arg40, NAP5; Leu31, C/E-1).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
371,
774-786)
copyright 2007.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Y.Koh,
and
R.M.Kini
(2008).
Anticoagulants from hematophagous animals.
|
| |
Expert Rev Hematol,
1,
135-139.
|
 |
|
|
|
|
 |
M.Hammwöhner,
and
A.Goette
(2008).
Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
|
| |
J Cardiovasc Pharmacol,
52,
18-27.
|
 |
|
|
|
|
 |
G.Faure,
V.T.Gowda,
and
R.C.Maroun
(2007).
Characterization of human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.
|
| |
BMC Struct Biol,
7,
82.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
| |